Metrics to compare | OIL | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipOILPeersSector | |
|---|---|---|---|---|
P/E Ratio | −24.2x | 5.2x | −0.4x | |
PEG Ratio | 0.63 | 0.08 | 0.00 | |
Price/Book | 8.1x | 2.6x | 2.6x | |
Price / LTM Sales | 72.8x | 2.1x | 3.1x | |
Upside (Analyst Target) | - | 91.3% | 49.3% | |
Fair Value Upside | Unlock | 10.3% | 6.7% | Unlock |
Optiscan Imaging Limited engages in the development, manufacture, and commercialization of endomicroscopic digital imaging technology solutions for medical, translational, and pre-clinical applications in Germany, China, Australia, and the United States. It offers InVue, a microscopic medical imaging device for precision surgery; InForm, a digital pathology imaging device for pathology workflows; InVivage, an intra-oral endomicroscope for oral imaging solutions; and ViewnVivo, a miniaturized in vivo imaging device for life sciences, pre-clinical and translational research. The company also provides InSpecta, a novel digital microscopic imaging device for veterinary medicine. Optiscan Imaging Limited was founded in 1994 and is headquartered in Mulgrave, Australia.